Published 22 hours ago • loading... • Updated 22 hours agoShow Less IconNImmune Biopharma Presented New Data at ACG 2026 Supporting the Efficacy and Safety of Innovative LANCL2 Medicines Targeting a Novel Mechanism in Hard-to-Treat IBD Summary by Enid News & EagleBLACKSBURG, Va.--(BUSINESS WIRE)--Oct 13, 2026-Share menu1 Articles1 ArticlesAllLeft1CenterRightSearch IconSort IconEnid News & EagleLean LeftFactualityOwnershipNImmune Biopharma Presented New Data at ACG 2026 Supporting the Efficacy and Safety of Innovative LANCL2 Medicines Targeting a Novel Mechanism in Hard-to-Treat IBDBLACKSBURG, Va.--(BUSINESS WIRE)--Oct 13, 2026-22 hours agoRead Full ArticleThink freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribeBlindspot Title And LogoStories disproportionately reported by the Left or the RightSee More BlindspotsCoverage DetailsTotal News Sources1Leaning Left1Leaning Right0Center0Last Updated21 hours agoBias Distribution100% LeftBias Distribution Too Big Arrow IconToo Big Arrow IconCaret Up Icon100% of the sources lean Left100% LeftL 100%Factuality Info IconTo view factuality data please Upgrade to PremiumOwnership Info IconTo view ownership data please Upgrade to VantageEnid News & Eagle broke the news 22 hours ago on Tuesday, October 13, 2026.Too Big Arrow IconCaret Down IconSources are mostly out of (0)Similar News TopicsBlacksburg, Virginia Plus IconShow AllBlindspot Title And LogoStories disproportionately reported by the Left or the RightSee More BlindspotsSimilar News TopicsBlacksburg, Virginia Plus IconShow All